Addition of amino acid moieties to lapatinib increases the anti-cancer effect via amino acid transporters
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Maeng, Han-Joo | - |
dc.contributor.author | Kim, Eun-Seo | - |
dc.contributor.author | Chough, Chieyeon | - |
dc.contributor.author | Joung, Misuk | - |
dc.contributor.author | Lim, Jee Woong | - |
dc.contributor.author | Shim, Chang-Koo | - |
dc.contributor.author | Shim, Won-Sik | - |
dc.date.available | 2020-02-28T18:43:28Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-01 | - |
dc.identifier.issn | 0142-2782 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12919 | - |
dc.description.abstract | Anti-cancer agents delivered to cancer cells often show multi-drug resistance (MDR) due to expulsion of the agents. One way to address this problem is to increase the accumulation of anti-cancer agents in cells via amino acid transporters. Thus, val-lapatinib and tyr-lapatinib were newly synthesized by adding valine and tyrosine moieties, respectively, to the parent anti-cancer agent lapatinib without stability issues in rat plasma. Val-lapatinib and tyr-lapatinib showed enhanced anti-cancer effects versus the parent lapatinib in various cancer cell lines, including human breast cancer cells (MDA-MB-231, MCF7) and lung cancer cells (A549), but not in non-cancerous MDCK-II cells. A glutamine uptake study revealed that both val-lapatinib and tyr-lapatinib, but not the parent lapatinib, inhibited glutamine transport in MDA-MB-231 and MCF7 cells, suggesting the involvement of amino acid transporters. In conclusion, val-lapatinib and tyr-lapatinib have enhanced anti-cancer effects, likely due to an increased uptake of the agents into cancer cells via amino acid transporters. The present data suggest that amino acid transporters may be an effective drug delivery target to increase the uptake of anti-cancer agents, leading to one method of overcoming MDR in cancer cells. Copyright (c) 2013 John Wiley & Sons, Ltd. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.relation.isPartOf | BIOPHARMACEUTICS & DRUG DISPOSITION | - |
dc.subject | BREAST-CANCER CELLS | - |
dc.subject | ESTER PRODRUGS | - |
dc.subject | GROWTH-INHIBITION | - |
dc.subject | TUMOR-CELLS | - |
dc.subject | SYSTEM-L | - |
dc.subject | FLOXURIDINE | - |
dc.subject | RECEPTOR | - |
dc.subject | GW572016 | - |
dc.subject | DRUG | - |
dc.subject | VALACYCLOVIR | - |
dc.title | Addition of amino acid moieties to lapatinib increases the anti-cancer effect via amino acid transporters | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000337525700005 | - |
dc.identifier.doi | 10.1002/bdd.1872 | - |
dc.identifier.bibliographicCitation | BIOPHARMACEUTICS & DRUG DISPOSITION, v.35, no.1, pp.60 - 69 | - |
dc.identifier.scopusid | 2-s2.0-84892188813 | - |
dc.citation.endPage | 69 | - |
dc.citation.startPage | 60 | - |
dc.citation.title | BIOPHARMACEUTICS & DRUG DISPOSITION | - |
dc.citation.volume | 35 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Shim, Won-Sik | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | multi-drug resistance (MDR) | - |
dc.subject.keywordAuthor | lapatinib | - |
dc.subject.keywordAuthor | val-lapatinib | - |
dc.subject.keywordAuthor | tyr-lapatinib | - |
dc.subject.keywordAuthor | amino acid transporters | - |
dc.subject.keywordAuthor | cancer cells | - |
dc.subject.keywordPlus | BREAST-CANCER CELLS | - |
dc.subject.keywordPlus | ESTER PRODRUGS | - |
dc.subject.keywordPlus | GROWTH-INHIBITION | - |
dc.subject.keywordPlus | TUMOR-CELLS | - |
dc.subject.keywordPlus | SYSTEM-L | - |
dc.subject.keywordPlus | FLOXURIDINE | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | GW572016 | - |
dc.subject.keywordPlus | DRUG | - |
dc.subject.keywordPlus | VALACYCLOVIR | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.